Fortitude Family Office »

Galectin Therapeutics shares owned by Fortitude Family Office

Quarter-by-quarter ownership of Galectin Therapeutics (GALT) shares owned by Fortitude Family Office from 13F filings

Historical chart of Fortitude Family Office investment in Galectin Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Galectin Therapeutics held by Fortitude Family Office consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Galectin Therapeutics by Fortitude Family Office

Quarter filed Position value Share count Share price at filing
2025-12-31 $374 90 4.16

More positions owned by Fortitude Family Office

Ishares Core S&p 500 Etf Etf (IVV)
Vanguard 0-3 Month Treasury Bill Etf Etf (VBIL)
Ishares Core Msci International Developed Markets Etf Etf (IDEV)
Apple Stock (AAPL)
Dimensional Inflation-protected Securities Etf Etf (DFIP)
Vanguard Ftse Developed Markets Etf Etf (VEA)
Knight-swift Transn Hldgs Inc Cl A Stock (KNX)
Imgp Dbi Managed Futures Strategy Etf Etf (DBMF)
Vanguard S&p 500 Etf Etf (VOO)
Vanguard Mid-cap Etf Etf (VO)
Avantis U.s. Large Cap Value Etf Etf (AVLV)
Dimensional Emerging Markets Core Equity 2 Etf Etf (DFEM)
Ishares Core Msci Emerging Markets Etf Etf (IEMG)
Invesco Senior Loan Etf Etf (BKLN)
Ishares Core S&p Mid-cap Etf Etf (IJH)

View all positions for Fortitude Family Office

Top funds holding Galectin Therapeutics

Vanguard Group
Advisor Group Holdings
BlackRock
Geode Capital Management
Susquehanna International
Marshall Wace
Sontag Advisory
LPL Financial
Commonwealth Equity Services
Vivaldi Capital Management
Geneos Wealth Management
State Street Corporation
Sovran Advisors
Retirement Guys Formula
Citadel Advisors

View all funds holding Galectin Therapeutics